Milrinone, Dobutamine Similarly Effective for Cardiogenic Shock
Incidence of adverse clinical outcomes, including in-hospital death, high in both groups in pragmatic randomized clinical trial
Opioid Tapering Tied to Higher Risk for Overdose, Mental Health Crisis
Rates of overdose, mental health crises increased after dose tapering among patients prescribed stable, long-term, higher-dose opioid therapy
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
Rate of disease-free survival at 24 months higher with pembrolizumab versus placebo following nephrectomy
Oral Atogepant Effective for Reducing Number of Migraine Days
Results also favored atogepant over placebo for most secondary end points; constipation, nausea most common adverse events
Almost 140,000 COVID-19 Deaths Averted With Vaccinations
Vaccination-associated reduction in deaths translated to statistical life benefit ranging from $625 billion to $1.4 trillion
COVID-19 Vaccine Effectiveness Down Against New Infections in New York
Recent decline in vaccine effectiveness against new COVID-19 cases coincided with increasing circulation of delta variant
FDA: Stop Using Eco-Med Ultrasound Gels, Lotions
Health care providers, facilities should stop using and discard all ultrasound gels and lotions due to risk for bacterial contamination
Biden Puts Pressure on Nursing Homes to Vaccinate Staff Against COVID-19
New mandate, which will come in the form of a regulation to be issued by CMS, could happen next month
Family Behind Oxycontin Denies Any Responsibility for Opioid Crisis
When asked if he carries any responsibility for the opioid crisis in the United States, Richard Sackler firmly replied: 'No'
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa
